Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
A close eye on the Ghana elections. The NDC have a good lead at the mo 55% vs 44%, enough to steel victory. Not good to be honest as the NDC is the party that fleeced Clon over Tano 2A and the party the BOD were bad mouthing about not playing with a straight bat ie corruption. If the NDC win then the Boulder will be firmly stuck on a ledge in my opinion. If the incumbent NPP get in then my timescales are as previously stated, if not and the NDC get in we are in for a rocky ride abd a lengthy outcome and possibly more court cases. Let’s hope the result pans out the way we want it. GL
Dutch - I am not posting here as I see no point in discussions, as I said previously For me covid delayed matters and Ghana has been impacted along with everyone else. Many projects have been cancelled which will positively impact the oil sp as supply weakens. Oil sp picks up and so do all the projects again, all at the same time may I add and there we have it another boom. When this will happen ..... this is the uncertainty maybe mid/late next year. Clon meetings in Ghana are due the back end of this year, now I think will be delayed further. This company does not burn a lot of cash so a slow burner. Bolivia much the same, although A bonus. IMHO no news now until next year and it in the meantime as I said these boards will be full of trolls. My conviction with Clon still speculative BUY but the end game has been delayed and badly impacted by the oil price due to COVID GLA and see you next year.
Pure manipulation by the MM , they eventually have to be seen. NickSmith any comments you clearly said there were no delayed trades, why were you so adement and defensive anbout that. In my 25 years experience of trading/investing this is one of the most obvious manipulation carried out and obviously there is a collusion. Paid trolls from the farm, who paid them. If this carrys on then this will become a matter for the establishment to deal with. This is a disgrace.
Mufta Sierra
According to Zacks Investment reaseach “Sierra Oncology, Inc. is a clinical-stage drug development company. It develops and markets drugs for the treatment of cancer. The product pipeline consists of SRA737 and SRA141. SRA737 is an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, a key cell cycle checkpoint and central regulator of the DNA Damage Response network. SRA141 is an orally available small molecule inhibitor of cell division cycle 7kinase. Sierra Oncology, Inc., formerly known as ProNAi Therapeutics, Inc., is headquatered in Vancouver, Canada. “ has changed the rating to BUY, also raised to a strong BUY.
IMGN632 Phase 1/2 study to determine the MTD and assess the safety, tolerability, PK, immunogenicity, and preliminary anti-leukemia activity. IMGN632 is a novel ADC that is a potential treatment for AML, blastic plasmacytoid dendritic cell neoplasm, myelodysplastic syndrome, B-cell acute lymphocytic leukemia and other CD123-positive malignancies. Data to be presented today. is this anything to do with CHk1 SRA737 (sorry for my lack of technical knowledge) Found this on twitter and thought would share this from the ASH conference in San Dieago
most likely collusion between the MM / brokers; price action has neem stinking the stench is unbearable. Most likely see the introduction of a serious MM once the rabbit escapes from the bag. get ready for the late reported trades tonight / tomorrow or when ever they feel like it. GLA